Form D — MindImmune Therapeutics, Inc.
0001792522-25-000002 · filed Dec 5, 2025
Offering amounts describe securities offered; amounts sold are issuer-reported as of each filing. Amendments can repeat earlier amounts. We do not add these figures into a capital-raised total. Missing amounts are not zero. Data coverage and methodology · How to interpret the amounts.
Check this disclosure on SEC EDGAR · More Pharmaceuticals filings
Offering
- Industry
- Pharmaceuticals
- Exemptions
- 06b
- Reported offering amount
- $12,000,000
- Reported amount sold
- $10,203,858
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- MindImmune Therapeutics, Inc.
- CIK
- 1792522
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- —
- Address
- 130 FLAGG ROAD
KINGSTON, RI 02881 - Phone
- 401-225-4612
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Isaac Stoner · Executive OfficerKingston, RI Find on LinkedIn ↗
-
Bradley Margus · DirectorKingston, RI Find on LinkedIn ↗
-
Christopher O'Donnell · DirectorKingston, RI Find on LinkedIn ↗
-
Reetika Bhardwaj · DirectorKingston, RI Find on LinkedIn ↗
-
Robert Nelson · Executive OfficerKingston, RI Find on LinkedIn ↗
Other filings from this issuer
View the original filing on SEC EDGAR ↗